Securecell
Founded 2009
About Securecell
We have been developing innovative solutions in bioprocess control for biotech and pharma for more than 25 years. This expertise and experience provides the fundament for the development of Seraccess, a truly disruptive Diabetes Therapy. We are experts in process analytics, data processing and automation in bioprocess engineering. As an engineering company, we develop turnkey, tailor-made complete solutions for complex tasks around the bioprocess. We rely on our broad experience and on predeveloped modular software and hardware concepts. Our venture division radically transforms diabetes treatment. Out technologyis the first and only technology for the treatment of diabetes which communicates and interacts directly with the blood – and is therefore the only solution which can meet the requirements for a true artificial pancreas. By taking away almost all action steps for patients, our technology radically transforms diabetes treatment for a better life.
Company Facts
- Founded: 2009
- Legal name: Securecell Ltd
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Website: securecell.ch
- Phone: +41447329070
Social Profiles
Canonical: https://fsome.com/organization/securecell-8307099 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.